apomorphine has been researched along with Tremor in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 30 (58.82) | 18.7374 |
1990's | 7 (13.73) | 18.2507 |
2000's | 2 (3.92) | 29.6817 |
2010's | 6 (11.76) | 24.3611 |
2020's | 6 (11.76) | 2.80 |
Authors | Studies |
---|---|
Kadiri, SK; Karkar, VV; Pal Roy, S; Rao Konijeti, S | 1 |
Abuleil, A; Ajagbe, AO; Alhendawi, BHM; Badri, R; Chaaya, C; Chalhoub, E; Korkusuz, AK; Onyeaka, H; Uwishema, O; Yücel, AN | 1 |
Antonini, A; Berg, D; Corvol, JC; Costa, J; Deuschl, G; Fabbrini, G; Ferreira, J; Foltynie, T; Henschke, N; Mir, P; Moro, E; Ruzicka, E; Schrag, A; Selikhova, M; Seppi, K; Śmiłowska, K; Taba, P; Villanueva, G | 2 |
Hallett, M; Katzenschlager, R; Pirker, W; Poewe, W | 1 |
Arif, C; Koneru, V; Ondo, WG | 1 |
Arabia, G; Augimeri, A; Barbagallo, G; Bianco, MG; Bifone, A; Bordier, C; Cerasa, A; Crasà, M; Fiorillo, A; Morelli, M; Nicolini, C; Nigro, S; Nisticò, R; Olivadese, G; Quattrone, A; Vescio, B | 1 |
Dafsari, HS; Florin, E; Gerick, F; Saur, J; Timmermann, L; von Papen, M | 1 |
Arabia, G; Augimeri, A; Barbagallo, G; Bianco, MG; Cerasa, A; Crasà, M; Morelli, M; Nicoletti, G; Nigro, S; Nisticò, R; Novellino, F; Olivadese, G; Quattrone, A; Salsone, M; Vescio, B | 1 |
Głowacka, U; Kosmowska, B; Ossowska, K; Wardas, J | 1 |
Du, GH; Du, LD; He, GR; Mu, X; Yuan, X | 1 |
Schnitzler, A; Südmeyer, M; Wojtecki, L | 1 |
STRUPPLER, A; VON UEXKULL, T | 1 |
BARCROFT, H; SCHWAB, RS | 1 |
Weiner, WJ | 1 |
Artaiz, I; Castro, E; Del Olmo, E; Innerárity, A; Labeaga, L; Orjales, A; Pazos, A; Zazpe, A | 1 |
Gerhart, JM; Hong, JS; Tilson, HA; Uphouse, LL | 1 |
Fukuda, T; Izumi, K; Kishita, C; Koja, T; Nomoto, M; Shimizu, T | 1 |
Agnoli, A; Baldassarre, M; D'Urso, R; Del Roscio, S; Falaschi, P; Frajese, G; Mearelli, S; Rocco, A; Ruggieri, S | 1 |
Banna, NR; Kurkjian, R | 1 |
Baskin, P; Salamone, J | 1 |
Benabid, AL; Benazzouz, A; Bressand, K; Gao, DM; Ilinsky, IA; Kultas-Ilinsky, K; Piallat, B | 1 |
Poewe, W; Schelosky, L; Scholz, U; Schrag, A | 1 |
Brodkin, J; Bymaster, F; Deng, C; Felder, C; Gomeza, J; Kostenis, E; Shannon, H; Wess, J; Xia, B; Zhang, L | 1 |
Hungerbühler, JP; Regli, F | 1 |
Blake, DJ; Somjen, GG; Zarzecki, P | 1 |
Asano, T; Matsumoto, Y; Mimura, Y; Mino, S; Nishimoto, A; Ohmoto, T; Yoshimura, Y | 1 |
Herberg, LJ; Wishart, TB | 1 |
Anagnoste, B; Battista, AF; Goldstein, M; Ogawa, M | 1 |
Klawans, HL; Moskovitz, C | 1 |
Kelly, DM; Naylor, RJ | 1 |
Doggett, NS; O'Farrell, SA | 1 |
Bastard, J; Chanelet, J; Emile, J; Truelle, JL | 1 |
Costall, B; Kelly, DM; Naylor, RJ | 1 |
Abraini, JH; Rostain, JC; Tomei, C | 1 |
Hughes, AJ; Lees, AJ; Stern, GM | 1 |
Frankel, JP; Hughes, A; Lees, AJ; Stern, GM | 1 |
Gerhart, JM; Hong, JS; Tilson, HA | 1 |
Brochet, D; Martin, P; Puech, AJ; Simon, P; Soubrié, P | 1 |
Chereshka, KS; Langel, IuL; Zharkovskaia, TA; Zharkovskiĭ, AM | 1 |
Buonamici, M; Khazan, N; Maj, R; Pagani, F; Rossi, AC | 1 |
Herr, DW; Tilson, HA | 1 |
Frances, H; Simon, P | 1 |
Timmerman, H; van Beek, MC | 1 |
Anagnoste, B; Battista, AF; Fuxe, K; Goldstein, M; Miyamoto, T | 1 |
Weissman, A | 1 |
Brinkmann, R; Strian, F | 1 |
Baylor, MR; Borgman, RJ; McPhillips, JJ; Stitzel, RE | 1 |
Angrist, B; Gershon, S; Rotrosen, J; Wallach, MB | 1 |
Ernst, AM; Hadzović, S | 1 |
Braham, J; Goldhammer, Y; Sarova-Pinhas, I | 1 |
5 review(s) available for apomorphine and Tremor
Article | Year |
---|---|
European Academy of Neurology/Movement Disorder Society-European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies.
Topics: Apomorphine; Deep Brain Stimulation; Humans; Neurology; Parkinson Disease; Quality of Life; Tremor | 2022 |
Pharmacological Treatment of Tremor in Parkinson's Disease Revisited.
Topics: Antiparkinson Agents; Apomorphine; Cholinergic Antagonists; Dopamine Agonists; Humans; Levodopa; Parkinson Disease; Tremor | 2023 |
[Current treatment strategies for Parkinson's disease].
Topics: Aged; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Apomorphine; Critical Care; Deep Brain Stimulation; Dementia; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Europe; Female; Humans; Infusion Pumps, Implantable; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Psychotic Disorders; Sleep Wake Disorders; Tremor | 2011 |
[Considerations in the drug treatment of parkinsonism (author's transl)].
Topics: Amantadine; Apomorphine; Bromocriptine; Dopamine; Ergolines; Extrapyramidal Tracts; Female; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinson Disease; Phosphodiesterase Inhibitors; Piribedil; Tremor | 1978 |
Monkeys with nigrostriatal lesions effects of monoaminergic drugs.
Topics: Amino Acids; Animals; Antiparkinson Agents; Apomorphine; Biogenic Amines; Carboxy-Lyases; Catechol O-Methyltransferase Inhibitors; Chlorocebus aethiops; Corpus Striatum; Drug Interactions; Haplorhini; Harmaline; Levodopa; Monoamine Oxidase Inhibitors; Movement Disorders; Substantia Nigra; Tremor | 1976 |
2 trial(s) available for apomorphine and Tremor
Article | Year |
---|---|
Reduction of Parkinsonian signs in patients with Parkinson's disease by dopaminergic versus anticholinergic single-dose challenges.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Apomorphine; Biperiden; Cholinergic Antagonists; Cross-Over Studies; Dopamine Agonists; Female; Humans; Hypokinesia; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Single-Blind Method; Tremor | 1999 |
[Polygraphic recording of tremor and of hypertonic phenomena. Application to the action of various drugs].
Topics: Antiparkinson Agents; Apomorphine; Clinical Trials as Topic; Dopa Decarboxylase; Drug Combinations; Drug Evaluation; Electrodiagnosis; Electromyography; Humans; Levodopa; Medical Records; Muscle Tonus; Oscillometry; Parkinson Disease; Piribedil; Tremor | 1975 |
44 other study(ies) available for apomorphine and Tremor
Article | Year |
---|---|
Antiparkinsonian activity of Tabebuia impetiginosa bark and biochemical analysis of dopamine in rat brain homogenates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adjuvants, Immunologic; Animals; Antioxidants; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Brain; Catalepsy; Catatonia; Dopamine; Haloperidol; Hypokinesia; Muscle Rigidity; Plant Bark; Rats; Reserpine; Tabebuia; Tremor; Water | 2022 |
The understanding of Parkinson's disease through genetics and new therapies.
Topics: alpha-Synuclein; Apomorphine; Dopaminergic Neurons; Humans; Hypokinesia; Parkinson Disease; Tremor | 2022 |
European Academy of Neurology/Movement Disorder Society - European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies.
Topics: Apomorphine; Deep Brain Stimulation; Humans; Neurology; Parkinson Disease; Quality of Life; Tremor | 2022 |
Task Specific Tremor in Parkinson's Disease Responds to Apomorphine.
Topics: Apomorphine; Dopamine; Humans; Levodopa; Parkinson Disease; Tremor | 2023 |
Apomorphine-induced reorganization of striato-frontal connectivity in patients with tremor-dominant Parkinson's disease.
Topics: Aged; Apomorphine; Dopamine Agonists; Electromyography; Female; Frontal Lobe; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neostriatum; Neural Pathways; Parkinson Disease; Single-Blind Method; Tremor | 2019 |
Phase-coherence classification: A new wavelet-based method to separate local field potentials into local (in)coherent and volume-conducted components.
Topics: Aged; Algorithms; Apomorphine; Beta Rhythm; Cohort Studies; Deep Brain Stimulation; Dopamine Agonists; Female; Humans; Implantable Neurostimulators; Male; Middle Aged; Motor Activity; Neurons; Parkinson Disease; Subthalamic Nucleus; Synaptic Transmission; Tremor; Wavelet Analysis | 2017 |
The placebo effect on resting tremor in Parkinson's disease: an electrophysiological study.
Topics: Accelerometry; Aged; Apomorphine; Dopamine Agonists; Female; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Placebo Effect; Statistics, Nonparametric; Treatment Outcome; Tremor | 2018 |
Apomorphine enhances harmaline-induced tremor in rats.
Topics: Animals; Apomorphine; Central Nervous System Stimulants; Dopamine Agonists; Drug Synergism; Harmaline; Male; Rats; Rats, Wistar; Tremor | 2015 |
Antagonism of quercetin against tremor induced by unilateral striatal lesion of 6-OHDA in rats.
Topics: Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Male; Molecular Structure; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Quercetin; Rats; Rats, Sprague-Dawley; Tremor | 2016 |
[Studies of mechanism of action of apormorphine on Parkinson's tremor].
Topics: Apomorphine; Humans; Parkinson Disease; Parkinsonian Disorders; Tremor | 1953 |
The effect of apomorphine and that of adrenalin, on the tremor of Parkinson's disease.
Topics: Apomorphine; Epinephrine; Humans; Parkinson Disease; Tremor | 1951 |
Research update on Parkinson's disease and other movement disorders: highlights from the Eighteenth Annual Symposium on the Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders, October 3, 2004, Toronto, Ontario, Canad
Topics: Antiparkinson Agents; Apomorphine; Glial Cell Line-Derived Neurotrophic Factor; Humans; Parkinson Disease; Tremor | 2005 |
In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
Topics: 5-Hydroxytryptophan; Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Avoidance Learning; Binding, Competitive; Catalepsy; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dopamine Plasma Membrane Transport Proteins; Drug Interactions; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Head Movements; Hypothermia; Jaw; Male; Mice; Motor Activity; Piperazines; Pyridazines; Pyridines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Serotonin Antagonists; Serotonin Receptor Agonists; Tremor | 2006 |
Chlordecone-induced tremor: quantification and pharmacological analysis.
Topics: Analysis of Variance; Animals; Apomorphine; Chlordecone; Dose-Response Relationship, Drug; Harmine; Insecticides; Male; Rats; Rats, Inbred F344; Serotonin; Time Factors; Tremor | 1982 |
Phenytoin potentiates methamphetamine-induced behavior in mice.
Topics: Animals; Apomorphine; Behavior, Animal; Brain; Carbamazepine; Drug Synergism; Humans; Male; Methamphetamine; Mice; Mice, Inbred Strains; Motor Activity; Phenytoin; Stereotyped Behavior; Tremor | 1984 |
Presynaptic neuron and postsynaptic dopamine receptor function in long term treatment of Parkinson's disease: a neuroendocrine study.
Topics: Aged; Apomorphine; Benserazide; Bromocriptine; Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Nomifensine; Parkinson Disease; Prolactin; Receptors, Dopamine; Selegiline; Tremor | 1980 |
Dopaminergic mechanisms in thiophene-2-aldoxime tremor.
Topics: Animals; Apomorphine; Catecholamines; Dextroamphetamine; Dopamine; Dopamine Antagonists; Haloperidol; Male; Mice; Oximes; Tremor | 1982 |
Vacuous jaw movements induced by acute reserpine and low-dose apomorphine: possible model of parkinsonian tremor.
Topics: Animals; Antipsychotic Agents; Apomorphine; Dopamine Agonists; Dose-Response Relationship, Drug; Jaw; Male; Muscarinic Antagonists; Neostriatum; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Reserpine; Scopolamine; Stereotyped Behavior; Tremor | 1996 |
High-frequency stimulation of the subthalamic nucleus suppresses experimental resting tremor in the monkey.
Topics: Animals; Apomorphine; Brain Stem; Cerebral Ventriculography; Electric Stimulation Therapy; Electrocoagulation; Functional Laterality; Macaca fascicularis; Male; Parkinson Disease, Secondary; Red Nucleus; Substantia Nigra; Thalamic Nuclei; Thalamus; Tremor | 1999 |
Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analgesia; Animals; Apomorphine; Brain; Corpus Striatum; Dopamine Agonists; Hypothermia; Mice; Mice, Knockout; Motor Activity; Oxotremorine; Prosencephalon; Quinpirole; Radioligand Assay; Receptor, Muscarinic M4; Receptors, Dopamine D1; Receptors, Muscarinic; Salivation; Tremor | 1999 |
Neurological disturbances, nigrostriate synapses, and iontophoretic dopamine and apomorphine after haloperidol.
Topics: Animals; Apomorphine; Cats; Caudate Nucleus; Dopamine; Evoked Potentials; Haloperidol; Iontophoresis; Motor Activity; Neurons; Posture; Substantia Nigra; Synapses; Synaptic Transmission; Tremor | 1977 |
Role of the caudate nucleus in production of dyskinesia [proceedings].
Topics: Animals; Apomorphine; Cats; Caudate Nucleus; Dopamine; Dyskinesia, Drug-Induced; Electric Stimulation; Levodopa; Movement Disorders; Neural Pathways; Substantia Nigra; Tremor | 1979 |
Central cholinergic mechanisms in electrical self-stimulation and in drug-induced tremor in rats.
Topics: Animals; Apomorphine; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Hypothalamus; Male; Oxotremorine; Parasympathetic Nervous System; Propranolol; Rats; Scopolamine; Self Stimulation; Tremor | 1979 |
Cyclizine-induced chorea. Observations on the influence of cyclizine on dopamine-related movement disorders.
Topics: Aged; Amphetamine; Animals; Apomorphine; Behavior, Animal; Chorea; Cyclizine; Dyskinesia, Drug-Induced; Face; Female; Guinea Pigs; Humans; Male; Oxotremorine; Scopolamine; Scopolamine Derivatives; Stereotyped Behavior; Tremor | 1977 |
An intracerebral injection study on the role of striatal dopamine and 5-hydroxytryptamine in the production of tremor by harmine.
Topics: Alkaloids; Animals; Apomorphine; Caudate Nucleus; Corpus Striatum; Dopamine; Globus Pallidus; Harmine; Injections; Male; Norepinephrine; Rats; Serotonin; Tremor | 1976 |
Modification of oxotremorine tremor and hypothermia by injections of drugs into the cerebral ventricles of the mouse.
Topics: Acetylcholine; Animals; Apomorphine; Atropine; Body Temperature; Dopamine; Drug Interactions; Female; Injections, Intraventricular; Male; Mice; Mice, Inbred Strains; Norepinephrine; Oxotremorine; Parasympathomimetics; Phentolamine; Propranolol; Serotonin; Tremor | 1976 |
The importance of 5-hydroxytryptamine for the induction of harmine tremor and its antagonism by dopaminergic agonists assessed by lesions of the midbrain raphe nuclei.
Topics: Alkaloids; Animals; Apomorphine; Dextroamphetamine; Harmine; Levodopa; Male; Mesencephalon; Nervous System Physiological Phenomena; Neural Pathways; Rats; Serotonin; Serotonin Antagonists; Tremor | 1976 |
Role of dopamine receptors in the occurrence of the behavioral motor disturbances in rats exposed to high pressure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Atmospheric Pressure; Behavior, Animal; Dopamine Agents; Epilepsies, Myoclonic; Ergolines; Haloperidol; High Pressure Neurological Syndrome; Injections, Intraventricular; Male; Motor Activity; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride; Tremor | 1991 |
Apomorphine in the diagnosis and treatment of parkinsonian tremor.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Apomorphine; Female; Humans; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Parkinson Disease; Tremor | 1990 |
Marijuana for parkinsonian tremor.
Topics: Antiparkinson Agents; Apomorphine; Carbidopa; Diazepam; Drug Combinations; Humans; Levodopa; Marijuana Smoking; Parkinson Disease; Tremor | 1990 |
Studies on the mechanism of chlordecone-induced tremor in rats.
Topics: Animals; Apomorphine; Ataxia; Chlordecone; Dose-Response Relationship, Drug; Harmine; Insecticides; Male; Motor Neurons; Neural Pathways; Oxotremorine; Picrotoxin; Rats; Rats, Inbred F344; Time Factors; Tremor | 1985 |
Comparison of clenbuterol enantiomers using four psychopharmacological tests sensitive to beta-agonists.
Topics: 5-Hydroxytryptophan; Adrenergic beta-Agonists; Animals; Apomorphine; Behavior, Animal; Body Temperature; Clenbuterol; Ethanolamines; Male; Mice; Motor Activity; Stereoisomerism; Tremor | 1985 |
[Significance of the dopamine-blocking and m-choline-blocking components in the antiapomorphine action of neuroleptics].
Topics: Animals; Antipsychotic Agents; Apomorphine; Arecoline; Choline; Dopamine Antagonists; Female; Male; Mice; Radioligand Assay; Rats; Rats, Inbred Strains; Stereotyped Behavior; Structure-Activity Relationship; Tremor | 1987 |
Tremor at rest episodes in unilaterally 6-OHDA-induced substantia nigra lesioned rats: EEG-EMG and behavior.
Topics: Animals; Apomorphine; Behavior, Animal; Electroencephalography; Electromyography; Hydroxydopamines; Male; Oxidopamine; Rats; Rats, Inbred Strains; Substantia Nigra; Tremor | 1986 |
Modulation of p,p'-DDT-induced tremor by catecholaminergic agents.
Topics: Animals; Apomorphine; Clonidine; DDT; Dopamine; Haloperidol; Male; Norepinephrine; Phenoxybenzamine; Prazosin; Propranolol; Rats; Rats, Inbred F344; Tremor; Yohimbine | 1987 |
Comparison of imipramine-imipraminium in mice. To elucidate central or peripheral origin of effects of imipramine.
Topics: Animals; Apomorphine; Body Temperature; Drug Synergism; Imipramine; Male; Mice; Motor Activity; Oxotremorine; Pupil; Reserpine; Tremor; Yohimbine | 1985 |
Some benzhydryl derivatives as central dopamine receptor stimulating agents.
Topics: Animals; Apomorphine; Behavior, Animal; Benzyl Compounds; Brain; Chlorpromazine; Dihydroxyphenylalanine; Dopamine; Haloperidol; Rats; Receptors, Drug; Reserpine; Tremor | 1974 |
Mechanisms involved in the control of extrapyramidal dysfunctions and in striatal dopamine synthesis.
Topics: Animals; Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Bucladesine; Carbidopa; Carbon Radioisotopes; Corpus Striatum; Depression, Chemical; Dopamine; Drug Therapy, Combination; Haloperidol; Haplorhini; Levodopa; Receptors, Drug; Stimulation, Chemical; Tremor | 1974 |
Psychopharmacological effects of thiothixene and related compounds.
Topics: Animals; Apomorphine; Avoidance Learning; Body Temperature; Catalepsy; Chlorpromazine; Dextroamphetamine; Discrimination, Psychological; Dogs; Drug Synergism; Ethanol; Hexobarbital; Humans; Male; Mice; Mortality; Phenothiazines; Prochlorperazine; Psychopharmacology; Rats; Reflex; Tranquilizing Agents; Tremor | 1968 |
[Apomorphine in the biochemical concept of Parkinson's tremor].
Topics: Animals; Apomorphine; Brain Chemistry; Dihydroxyphenylalanine; Drug Therapy, Combination; Humans; Parkinson Disease; Receptors, Drug; Tremor | 1974 |
Alpha-methyldopamine derivatives. Synthesis and pharmacology.
Topics: Animals; Apomorphine; Blepharoptosis; Body Temperature; Depression, Chemical; Dihydroxyphenylalanine; Dopamine; Dopamine Antagonists; Drug Interactions; Haloperidol; Methane; Mice; Motor Activity; Oxotremorine; Receptors, Drug; Reserpine; Time Factors; Tremor | 1974 |
Antagonism of apomorphine-induced sterotypy and emesis in dogs by thioridazine, haloperidol, and pimozide.
Topics: Animals; Apomorphine; Behavior, Animal; Blood-Brain Barrier; Chemoreceptor Cells; Corpus Striatum; Dogs; Drug Antagonism; Female; Haloperidol; Male; Pimozide; Premedication; Thioridazine; Time Factors; Tremor; Vomiting | 1972 |
The effect of 5-hydroxytryptamine and 5-hydroxytryptophan on extra-pyramidal function.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Basal Ganglia; Behavior, Animal; Dihydroxyphenylalanine; Extrapyramidal Tracts; Iproniazid; Male; Movement; Rats; Serotonin; Substantia Nigra; Tremor | 1969 |
Apomorphine in Parkinsonian tremor.
Topics: Apomorphine; Humans; Injections, Intravenous; Parkinson Disease; Tremor | 1970 |